Location History:
- Bunkyo, JP (1993)
- Tokyo, JP (1999 - 2013)
Company Filing History:
2 out of 10,273 
1 out of 305 
1 out of 1 Years Active: 1993-2013
Title: The Innovative Contributions of Hideo Yagita
Introduction
Hideo Yagita, an accomplished inventor based in Tokyo, Japan, has made significant strides in the field of biomedicine. With a portfolio of six patents, he is recognized for his innovative approaches to therapeutic and diagnostic strategies, particularly through his work on monoclonal antibodies.
Latest Patents
One of Yagita's latest patents is focused on a neutralizing monoclonal antibody against human DLL4. This invention provides a binding protein capable of binding to delta-like ligand 4 (DLL4), along with various methods and applications in therapy, diagnosis, or imaging. The patent also outlines the production of fusion proteins and protein conjugates, as well as nucleic acid molecules encoding the binding proteins, showcasing a comprehensive approach to targeting DLL4.
Another notable patent is centered around the monoclonal antibody that specifically reacts with Fas ligand and its production process. This invention includes a method for detecting Fas ligand in solution, hybridomas that produce the monoclonal antibody, and a detection kit containing multiple monoclonal antibodies against Fas ligand. This work not only enhances the understanding of Fas ligand interactions but also contributes to advancements in diagnostic tools and therapeutic options.
Career Highlights
Yagita has an impressive career trajectory, having worked with renowned companies such as Sumitomo Electric Industries, Limited and Kanebo, Limited. Throughout his career, he has focused on the development of groundbreaking biomedical innovations that bridge the gap between research and practical application.
Collaborations
During his professional journey, Yagita has collaborated with notable individuals, including Ko Okumura and Motomi Nakata. These partnerships have likely fostered an environment of creativity and innovation, further enriching his contributions to the field of medicine.
Conclusion
Hideo Yagita's innovative spirit and contributions to the field of biomedical inventions, particularly in monoclonal antibodies, highlight the importance of ongoing research and development. His patents not only exhibit his ingenuity but also pave the way for new therapeutic and diagnostic advancements in medicine. Through his work, Yagita continues to inspire future generations of inventors and researchers in the industry.